Venker Eric bought IMVT

July 28, 2025 · Form 4 insider transaction

Venker Eric bought 189,900 shares of Immunovant, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
189,900
Price
$0.00
Total value
N/A
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 28, 2025
Filing dateJuly 30, 2025
Shares owned after189,900
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

These options were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). 25% of the shares underlying the option shall vest on April 21, 2026, and the remaining shares subject to the option shall vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer or an affiliate on each such date.

View the original Form 4 on SEC EDGAR